VRise Therapeutics, Inc. Alternatives & Competitors

12 companies similar to VRise Therapeutics, Inc. — A Precision Oncology Company

Incyclix Bio

Regaining Cell Cycle Control

13 Series B $64.00M

Durham, United States

Biotechnology Health Care +2

T-Therapeutics Ltd

Making T-Cell Receptor Biologics a Reality

64 Series A $48.00M

Cambridge, United Kingdom

Biotechnology Health Care

OncoResponse

Interrogating for Cures

10 Unknown $117.10M

Houston, United States

Biopharma Biotechnology +2

Affini-T Therapeutics

Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...

11 Series Unknown $175.00M

Watertown, United States

Biotechnology Health Care +1

Track all VRise Therapeutics, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Kestrel Therapeutics

We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...

23 Series A $40.00M

Watertown, United States

Biopharma Biotechnology +1

Cybrexa Therapeutics

Changing the paradigm for cancer treatment through the development of antigen-independent...

11 Series B $44.40M

New Haven, United States

Biotechnology Health and Wellness +1

Oncotelic

AI driven developer of immunotherapeutics against cancer and covid-19 and other viruses

Agoura Hills, United Stat...

Health and Wellness Pharmaceutical

Cimeio Therapeutics

Reinventing cell therapy through our leadership in the emerging field of epitope shielding

16 Series A $50.00M

Cambridge, United States

PhotonPharma

An immuno-oncology company unleashing the body to fight cancer

8 Seed $4.30M

Fort Collins, United Stat...

Biosceptre International Limited

Pioneering the development of a multi-targeted universal CAR-T system incorporating our nf...

15 Series A $23.60M

Cambridge, United Kingdom

Biotechnology Life Sciences +1

Radionetics Oncology

Discovering and developing novel radiotherapeutics for the treatment of cancer.

48 Series A $135.00M

San Diego, United States

Health Care Health and Wellness +1

PhoreMost Ltd

Drugging the Undruggable®

33 Series B $63.80M

United Kingdom

Biopharma Biotechnology +1

About VRise Therapeutics, Inc.

A Precision Oncology Company

Services

Discovery and development of novel small molecules, Targeting cancer growth pathways, Focusing on RAS gene mutations

Target Customers

Oncology researchers, Biopharmaceutical companies, Health care providers specializing in cancer treatments, Patients with RAS-driven cancers

Taxonomy

Precision Oncology, Cancer Treatment, Precision Medicine, Small Molecule Development, Proprietary Discovery Engine, Cancer Pathways, Oncology Drug Discovery, Clinical Development, Cancer Research, Transformative Cancer Therapies, Cancer Proliferation, Cancer Differentiation

Business Model

B2B, D2C

Revenue Model

Licensing, Product Sales, Performance Based

Frequently Asked Questions

Top alternatives to VRise Therapeutics, Inc. include Incyclix Bio, T-Therapeutics Ltd, OncoResponse, Affini-T Therapeutics, Kestrel Therapeutics. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to VRise Therapeutics, Inc. based on industry overlap, target customers, and business model.

A Precision Oncology Company

Don't just read about them. Follow them.

BounceWatch watches VRise Therapeutics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

VRise Therapeutics, Inc. Profile Incyclix Bio Alternatives T-Therapeutics Ltd Alternatives OncoResponse Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at VRise Therapeutics, Inc. on 10 Mar 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.